All News #Library
Biotech
Vivace Therapeutics` VT3989, Shows Strong Antitumor Activity
19 Oct 2025 //
PR NEWSWIRE
Vivace Hits High Note In Midstage Mesothelioma Trial
19 Oct 2025 //
FIERCE BIOTECH
Vivace Therapeutics To Present New Clinical Data at ESMO Congress
09 Oct 2025 //
PR NEWSWIRE
Vivace Therapeutics` VT3989 Granted Fast Track Designation by US
08 Oct 2025 //
PR NEWSWIRE

Market Place
Sourcing Support